File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors

TitleA Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors
Authors
Issue Date2015
Citation
Cancer Chemotherapy and Pharmacology, 2015, v. 75 n. 2, p. 343-352 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/207852

 

DC FieldValueLanguage
dc.contributor.authorUronis, HEen_US
dc.contributor.authorJia, Jen_US
dc.contributor.authorBendell, Jen_US
dc.contributor.authorHoward, Len_US
dc.contributor.authorReady, NAen_US
dc.contributor.authorLee, PAen_US
dc.contributor.authorStarr, MDen_US
dc.contributor.authorDellinger, Aen_US
dc.contributor.authorPang, HMHen_US
dc.contributor.authorNixon, ABen_US
dc.date.accessioned2015-01-19T11:23:21Z-
dc.date.available2015-01-19T11:23:21Z-
dc.date.issued2015en_US
dc.identifier.citationCancer Chemotherapy and Pharmacology, 2015, v. 75 n. 2, p. 343-352en_US
dc.identifier.urihttp://hdl.handle.net/10722/207852-
dc.languageengen_US
dc.relation.ispartofCancer Chemotherapy and Pharmacologyen_US
dc.titleA Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumorsen_US
dc.typeArticleen_US
dc.identifier.emailPang, HMH: herbpang@hku.hken_US
dc.identifier.authorityPang, HMH=rp01857en_US
dc.identifier.doi10.1007/s00280-014-2647-xen_US
dc.identifier.hkuros242258en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats